These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25661364)
1. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables. Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364 [TBL] [Abstract][Full Text] [Related]
2. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer. Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430 [TBL] [Abstract][Full Text] [Related]
3. Circulating annexin A2 as a biomarker in patients with pancreatic cancer. Karabulut M; Afsar CU; Serilmez M; Karabulut S J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663 [TBL] [Abstract][Full Text] [Related]
4. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer. Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899 [TBL] [Abstract][Full Text] [Related]
5. Prognostic and diagnostic significance of annexin A2 in colorectal cancer. Yang T; Peng H; Wang J; Yang J; Nice EC; Xie K; Huang C Colorectal Dis; 2013 Jul; 15(7):e373-81. PubMed ID: 23489866 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer. Yang J; Yang F; Nie J; Zou X; Tian H; Qin Y; Liu C Cancer Biomark; 2015; 15(2):205-11. PubMed ID: 25519022 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer. Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D Biomed Pharmacother; 2015 Mar; 70():19-23. PubMed ID: 25776473 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Ji NY; Park MY; Kang YH; Lee CI; Kim DG; Yeom YI; Jang YJ; Myung PK; Kim JW; Lee HG; Kim JW; Lee K; Song EY Int J Mol Med; 2009 Dec; 24(6):765-71. PubMed ID: 19885616 [TBL] [Abstract][Full Text] [Related]
9. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer. Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595 [TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients. Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer. Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115 [TBL] [Abstract][Full Text] [Related]
12. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome. Tas F; Bilgin E; Karabulut S; Tastekin D; Duranyildiz D Mol Clin Oncol; 2016 Apr; 4(4):655-659. PubMed ID: 27073685 [TBL] [Abstract][Full Text] [Related]
13. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker. Wang CS; Wu TL; Tsao KC; Sun CF Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. Sun Z; Zhang N World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664 [TBL] [Abstract][Full Text] [Related]
15. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer. Tas F; Bilgin E; Karabulut S; Duranyildiz D Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559 [TBL] [Abstract][Full Text] [Related]
18. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis. Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335 [TBL] [Abstract][Full Text] [Related]
19. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway. Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum caveolin-1 levels in melanoma patients. Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]